Latest news for MusclePharm (OTC:MSLPQ) Stock

MusclePharm Corporation is a performance lifestyle company. It develops, manufactures, markets and distributes branded nutritional supplements. It offers various types of powders, capsules, tablets and gels. Geographically, the firm has its business presence across the region of US and in the international market of which the US accounts for the majority of revenue. MusclePharm's Hybrid series products include Assault, Combat Protein Powder, BCAA 3:1:2, CLA Core, Fish Oil, Combat Crunch Protein Bars, glutamine, carnitine, Combat Crunch, Protein Crisp, Organic Protein, and Protein Cookie. The group sells its products to various fitness enthusiasts, such as professional, combat sport, weight training, bodybuilding, running, and various team and individual sports, and others.

MusclePharm Corp

News

Management

Metalla Royalty & Streaming Appoints Jason Cho As President Effective Immediately

SolarMax Technology, Inc. (Nasdaq SMXT) ("SolarMax" or the "Company"), an integrated solar energy company, announced that it plans to offer engineering, procurement and construction services, known as EPC services, for large scale solar systems in the United States, which would include both solar power and EV charging stations. As the initial step in this business plan, SolarMax has signed a non-binding memorandum of understanding for its first major commercial solar installation project in the United States. This proposed project, to be located in Las Vegas, marks a potentially significant milestone in SolarMax' strategy to offer large scale EPC services in the U.S. EPC services encompass the comprehensive management of a solar project from the initial feasibility studies and design through procurement and construction.

Global

SMXT

SolarMax Technology Plans To Offer Engineering, Procurement And Construction Services In The United States; Signs MOU For First Major Commercial Solar Installation Project

Stifel analyst Benjamin Nolan maintains Costamare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMRE#NYSE">CMRE</a>) with a Hold and raises the price target from $12 to $14.

Price Target

Analyst Ratings

CMRE

Stifel Maintains Hold on Costamare, Raises Price Target to $14

Keybanc analyst Thomas Blakey maintains Appian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPN#NASDAQ">APPN</a>) with a Overweight and raises the price target from $37 to $41.

APPN

Keybanc Maintains Overweight on Appian, Raises Price Target to $41

Studies Pre-Funded, No Additional Capital Needed; Expected Completion Early Q3 2024

Biotech

General

MGRX

Mangoceuticals Initiates Efficacy Studies On Patented Respiratory Illness Prevention Technology In Collaboration With Vipragen Biosciences And IntraMont Technologies

Earnings

PMEC

Primech Holdings FY24 Revenue $72.5M, Up 5.1% YoY, Contracted Revenues As Of Mar 31 Were $144.4M

LCNB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCNB#NASDAQ">LCNB</a>) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.18 by 61.11 percent. This is a 35.56 percent decrease over earnings of $0.45 per share from the same period last year. The company reported quarterly sales of $19.30 million which beat the analyst consensus estimate of $17.20 million by 12.19 percent. This is a 8.27 percent increase over sales of $17.82 million the same period last year.

LCNB

LCNB Q2 Adj $0.29 Beats $0.18 Estimate, Sales $19.30M Beat $17.20M Estimate

Small Cap Consumer Research analyst Eric Beder reiterates Guess (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GES#NYSE">GES</a>) with a Buy and maintains $37 price target.

Reiteration

Small Cap Consumer Research Reiterates Buy on Guess, Maintains $37 Price Target

U.S. stock futures were lower this morning, with the Nasdaq futures dipping around 200 points on Wednesday.
Shares of Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) fell sharply in today's pre-market trading following <a href="https://www.benzinga.com/news/earnings/24/07/39918390/tesla-q2-earnings-highlights-revenue-beat-eps-miss-robotaxi-update-2024-growth-rate-to-be-notably-l">second-quarter results</a>.
Tesla reported second-quarter revenue of $25.5 billion, up 2% year-over-year. The revenue total beat a Street consensus estimate of $24.73 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. The company reported earnings per share of 52 cents in the second quarter, down 43% year-over-year. The earnings per share missed a Street consensus estimate of 62 cents per share.
The company reported second-quarter deliveries of 443,956 vehicles and production of 410,831 vehicles, down 5% and 14% year-over-year, respectively.
Tesla shares dipped 7.2% to $228.56 in the pre-market trading session.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Wheels Up Experience Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UP#NYSE">UP</a>) shares dipped 9.8% to $3.00 in pre-market trading. Wheels Up Experience will release its second quarter financial results on Thursday, Aug. 8.</li>
<li>SFL Corporation Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SFL#NYSE">SFL</a>) shares fell 9.3% to $12.65 in pre-market trading after the company announced an offering of 8 million common shares.</li>
<li>Serve Robotics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) shares declined 7.5% to $8.70 in pre-market trading after gaining 7% on Tuesday.</li>
<li>Deutsche Bank Aktiengesellschaft (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DB#NYSE">DB</a>) shares fell 7.5% to $15.77 in pre-market trading following second-quarter earnings.</li>
<li>Geron Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GERN#NASDAQ">GERN</a>) shares declined 6.9% to $4.30 in pre-market trading after the company announced the departure of CCO Anil Kapur.</li>
<li>Kanzhun Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZ#NASDAQ">BZ</a>) shares fell 5.8% to $15.00 in pre-market trading.</li>
<li>Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) shares declined 3.2% to $176.00 in pre-market trading. Alphabet reported upbeat earnings and sales results for its second quarter on Tuesday. The company also announced a cash dividend of 20 cents per share to be paid on Sept.16 to shareholders of record as of Sept. 9.</li>
<li>Visa Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) shares fell 3% to $256.94 in pre-market trading following third-quarter results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39924560/us-stocks-end-lower-as-investor-optimism-decreases-ahead-of-big-tech-earnings">US Stocks End Lower As Investor Optimism Decreases Ahead Of Big Tech Earnings</a></li>
</ul>

Pre-Market Outlook

Markets

Movers

Trading Ideas

GERN

GOOGL

SERV

TSLA

Tesla Posts Weak Earnings, Joins Visa, Deutsche Bank And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Banco Santander (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSBR#NYSE">BSBR</a>) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.16 by 37.5 percent. This is a 29.41 percent increase over earnings of $0.17 per share from the same period last year. The company reported quarterly sales of $3.825 billion which beat the analyst consensus estimate of $3.556 billion by 7.58 percent. This is a 66.65 percent decrease over sales of $11.470 billion the same period last year.

Earnings Beats

BSBR

Banco Santander Q2 2024 GAAP EPS $0.22 Beats $0.16 Estimate, Sales $3.825B Beat $3.556B Estimate

FLEX

Flex Says It Has Initiated An Executive Search Process To Identify A Permanent CFO

Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has finalized partnerships with premier testing laboratories.

GXAI

Gaxos Health Announces Strategic Partnerships With Leading Testing Laboratories, To Optimize Human Performance By Providing Customized Health And Wellness Plans As Well As Coaching Through Science And Technology

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a <a href="https://www.benzinga.com/yield-investments">high dividend payout</a>. 
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.
<h3 class="wp-block-heading">Kellanova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/K#NYSE">K</a>)</h3>
<ul>
<li>Dividend Yield: 3.96%</li>
<li>B of A Securities analyst Bryan Spillane maintained a Neutral rating and cut the price target from $64 to $62 on July 10. This analyst has an accuracy rate of 69%.</li>
<li>JP Morgan analyst Ken Goldman maintained a Neutral rating and raised the price target from $59 to $66 on May 3. This analyst has an accuracy rate of 80%.</li>
<li>Recent News: Kellanova will issue its second quarter financial results on Thursday, Aug. 1.</li>
<li><a href="https://pro.benzinga.com/dashboard">Benzinga Pro's real-time newsfeed</a> alerted to latest Kellanova news</li>
</ul>
<h3 class="wp-block-heading">Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>)</h3>
<ul>
<li>Dividend Yield: 4.75%</li>
<li>Stifel analyst Matthew Smith maintained a Buy rating and raised the price target from $108 to $115 on April 24. This analyst has an accuracy rate of 60%.</li>
<li>Argus Research analyst David Colemandowngraded the stock from Buy to Hold on March 5. This analyst has an accuracy rate of 63%.</li>
<li>Recent News: On July 23, Philip Morris International reported better-than-expected second-quarter financial results and raised its FY24 adjusted EPS guidance.</li>
<li>Benzinga Pro's charting tool helped identify the <a href="https://pro.benzinga.com/dashboard">trend in PM's stock</a>.</li>
</ul>
<h3 class="wp-block-heading">Altria Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>)</h3>
<ul>
<li>Dividend Yield: 7.98%</li>
<li>Stifel analyst Matthew Smithreiterated a Buy rating with a price target of $50 on March 25. This analyst has an accuracy rate of 60%.</li>
<li>Morgan Stanley analyst Pamela Kaufman reiterated an Equal-Weight rating with a price target of $45 on July 18, 2023. This analyst has an accuracy rate of 69%.</li>
<li>Recent News: Altria Group will report its second-quarter and first-half business results on July 31.</li>
<li>Benzinga Pro's signals feature notified of a potential <a href="https://pro.benzinga.com/dashboard">breakout in MO shares</a>.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39907046/best-buy-kroger-and-2-other-stocks-insiders-are-selling">Best Buy, Kroger And 2 Other Stocks Insiders Are Selling</a></li>
</ul>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>

Dividends

Wall Street's Most Accurate Analysts Weigh In On 3 Risk Off Stocks Delivering High-Dividend Yields

Stock Split

SPGC

Sacks Parente Announces 1-For-10 Reverse Stock Split, Effective Jul. 30

Fly-E Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYE#NASDAQ">FLYE</a>) ("Fly-E" or the "Company"), an electric vehicle company engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters, and related accessories, today announced the upcoming launch of three new electric motorcycle models. These models, the DP, EK PRO, and DT, are scheduled for official unveiling and launch in New York at the end of October 2024.

FLYE

Fly-E Group To Launch The DP, EK PRO, And DT, Are Scheduled For Official Unveiling And Launch In New York At The End Of October 2024.

Flex Says Paul Lundstrom Will Step Down As Chief Financial Officer Effective July 31, Jaime Martinez Will Assume The Role Of Interim Chief Financial Officer

Stifel analyst Benjamin Nolan maintains Ardmore Shipping (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASC#NYSE">ASC</a>) with a Buy and raises the price target from $22 to $24.

Stifel Maintains Buy on Ardmore Shipping, Raises Price Target to $24

Needham analyst Ami Fadia reiterates Sage Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGE#NASDAQ">SAGE</a>) with a Hold.

SAGE

Needham Reiterates Hold on Sage Therapeutics

AMSC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSC#NASDAQ">AMSC</a>), a&nbsp;leading system provider of megawatt-scale power resiliency solutions that&nbsp;orchestrate&nbsp;the rhythm and harmony of power on the grid&#x2122;, and protect and expand the capability of our Navy's fleet, today announced it has received an order worth over $12 million for its 3 megawatt (MW) class wind turbine electrical control systems (ECS) from Inox Wind Limited (Inox), India's premium wind turbine manufacturer. AMSC expects to ship most of these ECS over the course of fiscal year 2024.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

MusclePharm

News

Latest news for MusclePharm (OTC:MSLPQ) Stock